SAS

2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID

Find entries where: SAS

is present as a standalone ligand in 6 entries

Find related ligands:

Chemical Component Summary
Name	2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID
Synonyms	SULFASALAZINE
Identifiers	2-hydroxy-5-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl-benzoic acid
Formula	C₁₈ H₁₄ N₄ O₅ S
Molecular Weight	398.39
Type	NON-POLYMER
Isomeric SMILES	c1ccnc(c1)NS(=O)(=O)c2ccc(cc2)/N=N/c3ccc(c(c3)C(=O)O)O
InChI	InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+
InChIKey	NCEXYHBECQHGNR-QZQOTICOSA-N

Chemical Details
Formal Charge	0
Atom Count	42
Chiral Atom Count	0
Bond Count	44
Aromatic Bond Count	18

Drug Info: DrugBank

DrugBank ID	DB00795
Name	Sulfasalazine
Groups	approved
Description	A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see mesalamine) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
Synonyms	5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid Salazosulfapyridinum 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid Salicylazosulfapyridine Sulfasalazina Salazosulfapyridine 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene Azopyrin Sulfasalazine Sulfasalazin Sulfasalazinum Salazosulfapiridina 2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid
Brand Names	Sulfasalazine Delayed-Release Apo Sulfasalazine Tab 500mg Azulfidine EN-tabs Azulfidine PMS-sulfasalazine-E.C. Tab 500mg Salazopyrin Tab 500mg Ratio-sulfasalazine Tab 500mg Salazopyrin Enema 3gm/100ml S.A.S. Enteric 500mg Salazopyrin En-tabs 500 mg Salazopyrin Enema 3.0gm/100ml Sas Tab 500mg Orb-sulfasalazine EC Sas Enema 3gm/100ml Ratio-sulfasalazine En Sulfasalazine EC Sulfasalazine PMS-sulfasalazine 500mg/tab USP
Indication	For the treatment of Crohn's disease and rheumatoid arthritis as a second-line agent.
Categories	Agents causing hyperkalemia Agents that produce hypertension Alimentary Tract and Metabolism Amides Aminosalicylate Analgesics Analgesics, Non-Narcotic Anti-Infective Agents Anti-Inflammatory Agents Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal (Non-Selective) Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents Antirheumatic Agents BCRP/ABCG2 Inhibitors BCRP/ABCG2 Substrates Central Nervous System Agents Gastrointestinal Agents Genito Urinary System and Sex Hormones Gynecological Antiinfectives and Antiseptics Immunosuppressive Agents Intestinal Antiinflammatory Agents Methemoglobinemia Associated Agents Nephrotoxic agents Non COX-2 selective NSAIDS OATP1B1/SLCO1B1 Inhibitors OATP1B3 inhibitors Organic Anion Transporting Polypeptide 2B1 Inhibitors Peripheral Nervous System Agents Salicylates Sensory System Agents Sulfonamides Sulfones Sulfur Compounds
ATC-Code	G01AE10 A07EC01
CAS number	599-79-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Arachidonate 5-lipoxygenase	MPSYTVTVATGSQWFAGTDDYIYLSLVGSAGCSEKHLLDKPFYNDFERGA...	unknown	inhibitor
Prostaglandin G/H synthase 2	MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...	unknown	inhibitor
Prostaglandin G/H synthase 1	MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFG...	unknown	inhibitor
Peroxisome proliferator-activated receptor gamma	MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDL...	unknown	agonist
Inhibitor of nuclear factor kappa-B kinase subunit alpha	MERPPGLRPGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLEL...	unknown	inhibitor
Inhibitor of nuclear factor kappa-B kinase subunit beta	MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQEL...	unknown	inhibitor
Cystine/glutamate transporter	MVRKPVVSTISKGGYLQGNVNGRLPSLGNKEPPGQEKVQLKRKVTLLRGV...	unknown	inhibitor
Acetyl-CoA acetyltransferase, mitochondrial	MAVLAALLRSGARSRSPLLRRLVQEIRYVERSYVSKPTLKEVVIVSATRT...	unknown	inhibitor
Thromboxane-A synthase	MEALGFLKLEVNGPMVTVALSVALLALLKWYSTSAFSRLEKLGLRHPKPS...	unknown	antagonist
Phospholipase A2	MKLLVLAVLLTVAAADSGISPRAVWQFRKMIKCVIPGSDPFLEYNNYGCY...	unknown	antagonist
ATP-binding cassette sub-family G member 2	MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKS...	unknown	substrate,inhibitor
Canalicular multispecific organic anion transporter 1	MLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGYLWLLAPWQLLH...	unknown	substrate
Proton-coupled folate transporter	MEGSASPPEKPRARPAAAVLCRGPVEPLVFLANFALVLQGPLTTQYLWHR...	unknown	inhibitor
Solute carrier organic anion transporter family member 1B1	MDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKS...	unknown	inhibitor
Solute carrier organic anion transporter family member 1B3	MDQHQHLNKTAESASSEKKKTRRCNGFKMFLAALSFSYIAKALGGIIMKI...	unknown	inhibitor
Solute carrier organic anion transporter family member 2B1	MGPRIGPAGEVPQVPDKETKATMGTENTPGGKASPDPQDVRPSVFHNIKL...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682